pyrazolanthrone has been researched along with Carcinoma, Lewis Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, YI; Jung, S; Li, CH; Lim, SH; Ryu, HH | 1 |
| Choi, JM; Jang, WY; Jeong, YI; Jung, S; Li, CH; Lim, SH | 1 |
| Jung, S; Jung, TY; Li, CH; Lim, SH; Moon, KS; Ryu, HH | 1 |
3 other study(ies) available for pyrazolanthrone and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Synergistic Effects of Radiotherapy With JNK Inhibitor-Incorporated Nanoparticle in an Intracranial Lewis Lung Carcinoma Mouse Models.
Topics: Animals; Apoptosis; Brain Neoplasms; Carcinoma, Lewis Lung; Caspase 3; Mice; Nanoparticles | 2023 |
Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Topics: Animals; Anthracenes; Apoptosis; Biological Availability; Brain Neoplasms; Carcinoma, Lewis Lung; DNA Damage; Drug Delivery Systems; Female; Gamma Rays; Humans; Hydrogen-Ion Concentration; JNK Mitogen-Activated Protein Kinases; Methyltransferases; Mice, Inbred C57BL; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Radiation-Sensitizing Agents; Tumor Microenvironment | 2019 |
Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Chemoradiotherapy; Dose-Response Relationship, Radiation; Female; Histones; JNK Mitogen-Activated Protein Kinases; Mice, Inbred C57BL; Neoplasm Transplantation; Phosphorylation; Protein Processing, Post-Translational; Radiation Tolerance; Signal Transduction | 2016 |